Elagolix with add-back therapy promising for endometriosis-associated pain: Ongoing phase 3 trial reveals Medha Baranwal25 July 2024 8:30 PM ISTUSA: In a significant advancement in the treatment of endometriosis, preliminary findings from an ongoing randomized Phase 3 trial have unveiled...
Sun Pharma Industries Gets CDSCO Panel Nod To Manufacture Market Elagolix Tablets 150 mg,200 mg Dr. Divya Colin6 April 2024 6:00 PM ISTNew Delhi: With the condition to be sold by retail under the prescription of a Gynaecologist only, pharmaceutical major Sun Pharma Industries has got...
Conduct BE and Phase III CT: CDSCO Panel Tells Alkem On Elagolix Tablets Dr. Divya Colin5 May 2023 6:00 PM ISTNew Delhi: In response to the drug major Alkem Laboratories' proposal to manufacture and market the GnRH receptor antagonist Elagolix, the Subject...
MSN Lab gets CDSCO Panel nod for phase III CT of Elagolix Tablets Dr. Divya Colin19 Feb 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Gets CDSCO Panel Nod To Study Elagolix tablet Dr. Divya Colin14 Oct 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Gets CDSCO Panel Nod To Study Elagolix 150 mg For Endometriosis Dr. Divya Colin15 Aug 2022 12:30 PM ISTNew Delhi: Denying the request to conduct Phase III study of Elagolix 200mg Tablets with test arm 2, the Subject Expert Committee (SEC) functional...
Elagolix may help reduce heavy bleeding in fibroids: NEJM Dr. Kamal Kant Kohli24 Jan 2020 4:01 PM ISTPHILADELPHIA - About 50 % of women with uterine fibroids-experience heavy menstrual bleeding and other symptoms. Thes women with fibroids with severe...
